- د.شيرين غالب
- د. محمد جاب الله ( زميلنا )
- د. مصطفى غانم 2026
- د. مصطفى غانم 2026
- تفريغ 2026HE
🖇 Human Genetically Controlled Marker Systems
Determine individual differences through:
📌 Blood group systems (ABO, Rh).
📌 Enzyme groups
Polymorphic enzymes located in RBCs.
📌 Protein groups
Haptoglobins, immunoglobulin types in plasma.
📌 HLA (Human Leukocyte Antigen)
Present on WBCs.
Highly complex → chance of two unrelated individuals having identical HLA type is extremely low.
🟠 Disputed Paternity – Key Situations
Babies claimed by two different sets of parents.
Accidental switching of babies in maternity units.
Father denying paternity.
Lost child recovered after long interval → identity must be confirmed.
🟣 Physician Responsibilities to Avoid Blood Incompatibility
📌 Accurate blood grouping (ABO + Rh) for donor and recipient before each transfusion.
📌 Direct cross-matching: donor blood + recipient blood → no agglutination.
📌 Avoid using Group O as a universal donor
Some O donors have potent agglutinins that can hemolyze A or B RBCs.
📌 Transfused blood must be Rh-negative, especially for female recipients.
📌 Avoid transfusing husband’s blood to his wife
Prevents future fetal complications.
📌 Donor must be free from infectious diseases
e.g., hepatitis viruses, HIV.
